Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study (Q52072195)
Jump to navigation
Jump to search
scientific article published in October 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study |
scientific article published in October 2000 |
Statements
Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study (English)
1 reference
1 reference
C Blomqvist
1 reference
H Holte
1 reference
J Bergh
1 reference
B Erikstein
1 reference
E Lidbrink
1 reference
H Lindman
1 reference
P Malmström
1 reference
P Kellokumpu-Lehtinen
1 reference
N O Bengtsson
1 reference
G Söderlund
1 reference
G Anker
1 reference
E Wist
1 reference
S Ottosson
1 reference
E Salminen
1 reference
P Ljungman
1 reference
J Nilsson
1 reference
N Wilking
1 reference
1 October 2000
1 reference
356
1 reference
9239
1 reference
1384-1391
1 reference